About 4 results
Open links in new tab
  1. New PCSK9 Gets Cholesterol to Target if Statins Can't - Medscape

    Apr 16, 2025 · An investigational PCSK9 inhibitor with a different mechanism from existing drugs in this class has been shown to safely and effectively lower cholesterol levels.

  2. Are We Reaching the End for Endocrine-Disrupting Chemicals?

    Jun 12, 2024 · The world is waking up to plastic pollution's impact on health as well as the environment, and a global treaty to end it is in the works.

  3. Pharmacodynamic Properties of Antiplatelet Agents - Page 3

    Ticagrelor Ticagrelor (AZD 6140) (Figure 3) is a nonthienopyridine, direct-acting selective antagonist of the ADP P2Y 12 receptor.

  4. Hazards of Triple Antithrombotic Therapy - Medscape

    Jul 8, 2009 · Combining warfarin with dual antiplatelet therapy is associated with significant bleeding hazards, and this is a growing problem with the aging of the population. Recommendations on how …